A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

Clinical trial NCT05827068 · COMPLETED

Trial details

NCT number: NCT05827068
Sponsor: ModernaTX, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Seasonal Influenza

Start date: 2023-03-27
Primary completion: 2023-11-20
Enrollment: 698

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.